Michael Dal Bello, a healthcare investment partner at Pritzker Group Private Capital, has been named president of the Healthcare Private Equity Association, a trade group comprised of more than 50 private equity firms representing 400 healthcare portfolio companies. As president, Mr. Dal Bello will lead the organization’s advocacy, research and communication efforts when he takes office in July. Prior to assuming the presidency, Mr. Dal Bello was a board member of the organization.
“I am honored to take leadership of this organization at such a pivotal time for the healthcare industry. Private equity plays a significant and constructive role in supporting the growth of leading healthcare companies, which provide the products and services that lead to effective, efficient and high-quality patient outcomes,” said Mr. Dal Bello
Mr. Dal Bello joined Pritzker Group Private Capital in December 2013 from Blackstone Group, where he invested more than $7 billion of equity capital in 13 transactions while helping to lead the firm’s sourcing efforts in healthcare. Before joining Blackstone, Mr. Dal Bello was an Associate at Hellman & Friedman where he was involved with the analysis and execution of private equity investments in the media and professional services sectors. Prior to that, he worked as a consultant at Bain & Company and also was a Research Associate at the China Center for Economic Research in Beijing. Mr. Dal Bello earned an MBA from Harvard Business School, an MA from Oxford University and undergraduate degrees from the Wharton School and the College of Arts and Sciences at the University of Pennsylvania.
The Healthcare Private Equity Association (HCPEA) was founded in 2010 by a group of private equity firms involved in healthcare. The organization advocates on behalf of members with government, represents the industry to the media and other organizations, and promotes knowledge sharing and best practices among association members. Member companies have a minimum of 3 healthcare related portfolio companies and are focused on investing in healthcare leveraged buyouts or late stage growth equity (www.hpea.org).
Founding Members of the HCPEA include: Abingworth; Apax Partners; Bain Capital; Bain Capital Ventures; Baird Capital Partners; Beecken Petty O’Keefe and Company; Blackstone; Charterhouse; Cressey & Co.; DW Healthcare Partners; Enhanced Equity Fund; Ferrer Freeman; Flexpoint Ford; Frazier; Frontenac; General Atlantic; Genstar Capital; Health Enterprise Partners; Kohlberg Kravis Roberts & Co.; Linden Capital Partners; Madison Dearborn Partners; MetalMark; MedEquity; MTS Health Advisors; Nautic Partners; Oak Hill Capital; Parthenon Capital Partners; Riordan, Lewis & Haden; Riverside Company; Roundtable Healthcare Partners; Sterling Partners; Summer Street Capital Partners; SV Life Sciences; TA Associates; TPG Capital; Vestar Capital Partners; Water Street Healthcare Partners; Waud Capital Partners and Welsh, Carson, Anderson & Stowe. HCPEA’s founding sponsors are Ernst & Young, McDermott Will & Emery and West Monroe Partners.
© 2014 PEPD • Private Equity’s Leading News Magazine • 2-25-14
